ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

HLN's Immunization Calculation Engine (ICE) is continually updated to support new COVID-19 recommendations

By: PRLog

MISSION VIEJO, Calif. - March 20, 2023 - PRLog -- HLN's Immunization Calculation Engine (ICE) open-source software system helps clinicians, public health, and individuals stay on top of ever-changing and increasingly complex immunization recommendations. For COVID-19 alone, HLN released more than ten updates to ICE since the pandemic began in 2020. These updates support accurate evaluation and forecasting of COVID-19 immunizations, helping ensure individuals stay up to date given the latest Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) recommendations.

In its latest update (v 1.38.1) released on March 17, 2023, HLN added support for additional COVID vaccines and made necessary changes to the booster recommendations. Additional DTP and Polio vaccines were also added, as well as some minor logic changes to rules related to Orthopoxvirus and Hep B. You can see release notes for all ICE versions, as well as complete documentation, runtime and source code.

ICE supports COVID-19 recommendations for FDA-authorized and ACIP-approved vaccines, WHO-authorized vaccines, and vaccine candidates active in U.S.-based clinical trials. HLN will continue to monitor vaccine updates to ensure ICE supports the latest immunization recommendations for children, adolescents, and adults for COVID-19 and across sixteen additional vaccine groups.

By translating recommendations into a rules-based service available for use in immunization information systems (IIS), electronic health record (EHR) systems, and personal health record (PHR) systems, ICE provides decision support on what immunizations are due and when. Recognized by the U.S. Department of Health and Human Services National Vaccine Program Office and the Digital Public Goods Alliance, ICE is an innovative tool to support clinical immunization workflows and decrease the burden of preventable disease. Interested to learn more about this free, open-source service and learn how it can support your immunization needs? See https://www.hln.com/ice/ and reach out to ice@hln.com.

About HLN

HLN is a leading public health informatics consulting company providing software development and technical support services to immunization information systems (IIS) as well as other public health systems for more than twenty-five years. HLN is focused on leveraging an open source collaborative development model as the most efficient and cost-effective way to build and support robust technical solutions that address pressing public health needs.

HLN's experience includes all phases of the lifecycle of public health systems projects, including IIS, from design and development to operations and support. HLN supports both waterfall and Agile methodologies depending on the needs of the client. Much of our open source work is focused on clinical decision support (CDS) applications built using OpenCDS, an open-source clinical decision support platform. This includes our Immunization Calculation Engine (ICE) and Reportable Condition Knowledge Management System (RCKMS). RCKMS supports the national strategy of electronic case reporting (eCR) to public health organizations. HLN is part of the eCR team which was recently awarded the CDC Excellence in Partnership Award and CSELS Director's Award for Innovation.

More information on HLN Consulting and its open source products can be found at https://www.hln.com.

Contact
Noam H. Arzt, PhD
***@hln.com

Photos: (Click photo to enlarge)

HLN Consulting, LLC Logo Ice Logo Transparent Iceclientscreensample Dpga Color L

Read Full Story - HLN's Immunization Calculation Engine (ICE) is continually updated to support new COVID-19 recommendations | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.